U.S. Government Partnering With Community Leaders to Increase COVID-19 Vaccine Uptake
The U.S. Department of Health and Human Services (HHS) has proposed an initiative called “The
Award Winning Investigative Journalist Provides Evidence of Origins of SARS-CoV-2
Although it has been suggested since the start of the pandemic in early 2020 that SARS-CoV-2, the new mutated coronavirus virus that causes COVID-19 disease, may have originated…
“Breakthrough Cases” of COVID-19 Emerging Among Fully Vaccinated Americans
The U.S. Centers for Disease Control and Prevention (CDC) recommends getting a COVID-19 vaccine, stating that, “COVID-19 vaccines are effective at protecting you from getting sick. Based on what we know about COVID-19 vaccines, people who have been fully vaccinated can start to do some things that they had stopped doing because of the pandemic.”1 […]
States Lining Up Against “Vaccine Immunity Passports”
Governors of several states in the U.S. have issued executive orders banning state agencies and corporations doing business in the state from requiring residents to provide proof of COVID-19 vaccination via a vaccine immunity passport in order to obtain public services or enter public venues. Florida and Texas Governors Sign Executive Orders Banning Vaccine Passports […]
Former CDC Director Believes Coronavirus Was Made in a Lab
If you ask the average person about how they think the SARS-CoV-2 virus came about, chances are they will say something like: “It started with an infected bat in a wet market in Wuhan, China and somehow managed to get into humans.” That is the theory that consistently has been promoted by many scientists and public health officials since the World Health Organization (WHO) declared a COVID-19 pandemic.
Moderna, Pfizer Test mRNA Experimental Biologics on Children
On Dec. 10, 2020, American biotechnology company Moderna, Inc., which is pioneering the development of experimental messenger RNA (mRNA) therapeutics and vaccines, gave a 12-year old a dose of the company’s mRNA-1273 vaccine in a Phase 2/3 study of the new vaccine. Moderna CEO Stephane Bancel said, “Our goal is to generate data in the […]